CA-July13-Doc.1

PRELIMINARY DRAFT AGENDA

52nd meeting of representatives of Members States Competent Authorities for the implementation of Directive 98/8/EC concerning the placing of biocidal products on the market

10-12July 2013

Starting at 09:30 on 10 July – Ending at 16:00 on 12July2013

Documents highlighted are not yet available on CIRCABC

1

10July
Registration 09:00 – 09:30
Morning Session / 09:30 – 13:00
  1. Adoption of the agenda
/ For adoption
CA-July13-Doc.1
  1. Adoption of the draft minutes of the previousCA meeting
/ For adoption
CA-July13-Doc.2
  1. Final discussions on draft regulatory measures

3.0Notes on the principles for taking decisions on the approval of active substances / For endorsement
CA-May13-Doc.3.0
CA-May13-Doc.3.0.a
3.1.Draft Commission implementing Regulation and draft assessment report for the approval of IPBC for PT 6 / For discussion
RMS: DK
CA-July13-Doc.3.1
CA-July13-Doc.3.1a
3.2.Draft Commission implementing Regulation and draft assessment report for the approval of Tebuconazole for PT 7 and 10 / For discussion
RMS: DK
CA-July13-Doc.3.2
CA-July13-Doc.3.2a
CA-July13-Doc.3.2b
3.3.Draft Commission implementing Regulation and draft assessment report for the approval of Benzoic acid for PT 3 and 4 / For discussion
RMS: DE
CA-July13-Doc.3.3
CA-July13-Doc.3.3a
CA-July13-Doc.3.3b
3.4.Draft Commission implementing Regulation and draft assessment report for the approval of Aluminium phosphide for PT 20 / For discussion
RMS: DE
CA-July13-Doc.3.4
CA-July13-Doc.3.4a
3.5.Draft Commission implementing Regulation and draft assessment report for the approval of Etofenprox for PT 18 / For discussion
RMS: AT
CA-July13-Doc.3.5
CA-July13-Doc.3.5a
3.6.Draft Commission implementing Regulation and draft assessment report for amending the conditions of approval of Nonanoic acid for PT 2 / For discussion
RMS: AT
CA-July13-Doc.3.6
CA-July13-Doc.3.6a
3.7.Draft Commission implementing Regulation and draft assessment report for the approval of Bromoacetic acid for PT 4 / For discussion
RMS: ES
CA-July13-Doc.3.7
CA-July13-Doc.3.7a
3.8.Draft Commission implementing Regulation and draft assessment report for the approval of Copper sulphate for PT 2 / For discussion
RMS: FR
CA-July13-Doc.3.8
CA-July13-Doc.3.8a
10July
Afternoon SESSION / 14:30 – 18:00
  1. First discussions on draft regulatory measures

4.1.Draft Commission implementing Regulation and draft assessment report for the approval of copper HDO for PT 8 / For discussion
RMS: AT
CA-July13-Doc.4.1
CA-July13-Doc.4.1a
4.2.Draft Commission implementing Regulation and draft assessment report for the approval of S-methoprene for PT 18 / For discussion
RMS: IE
CA-July13-Doc.4.2
CA-July13-Doc.4.2a
4.3.Draft Commission implementing Regulation and draft assessment report for the approval of octanoic acid for PT 4 and 18 / For discussion
RMS: AT
CA-July13-Doc.4.3
CA-July13-Doc.4.3a
4.4.Draft Commission implementing Regulation and draft assessment report for the approval of decanoic acid for PT 4, 18 and 19 / For discussion
RMS: AT
CA-July13-Doc.4.4
CA-July13-Doc.4.4a
4.5.Draft Commission implementing Regulation, draft assessment report for the approval of iodine(including PVP iodine) for PT 1, 3, 4 and 22 and note on the inclusion of iodine / For discussion
RMS: SE
CA-July13-Doc.4.5
CA-July13-Doc.4.5a
CA-July13-Doc.4.5b
4.6.Draft Commission implementing Regulation and draft assessment report for the approval of thralopyril for PT 21 / For discussion
RMS: UK
CA-July13-Doc.4.6
CA-July13-Doc.4.6a
4.7.Draft Commission implementing Regulation and draft assessment report for the approval of zineb for PT 21 / For discussion
RMS: IE
CA-July13-Doc.4.7
CA-July13-Doc.4.7a
11 July
Morning SESSION / 9:30 – 12:30
4.8.Proposal for a Commission implementing decision rejecting a request to refuse the authorisation of a biocidal product containing difenacoum notified by the Netherlands in accordance with Directive 98/8/EC of the European Parliament and of the Council / For discussion
CA-July13-Doc.4.8
4.9.Proposal for a Commission implementing decision approving restrictions of the authorisation of a biocidal product containing bromadiolone notified by Germany in accordance with Directive 98/8/EC of the European Parliament and of the Council / For discussion
CA-July13-Doc.4.9
4.10.Proposal for a Commission implementing Regulation specifying the procedures to amendAnnex I / For discussion
CA-July13-Doc.4.10
4.11.Proposal for a Commission Regulation (delegated act) concerning the review programme / For discussion
CA-July13-Doc.4.11
4.12.Proposal for a Commission Regulation (delegated act) laying down supplementary rules for the renewal of authorisations subject to mutual recognition in accordance with Art. 40 of the BPR / For discussion
CA-July13-Doc.4.12
4.13.Commission decision concerning the placing on the market in the UK for essential use of biocidal products containing copper / For discussion
CA-July13-Doc.4.13
4.14.Commission decision concerning the placing on the market in Norway for essential use of biocidal products containing copper / For discussion
CA-July13-Doc.4.14
4.15.Commission decision concerning the placing on the market in Spain for essential use of biocidal products containing copper / For discussion
CA-July13-Doc.4.15
11 July
Afternoon Session / 14:30 – 18:00
  1. New Regulation

5.1.Preparation of implementation
5.1.a.Tasks overview / For information
CA-July13-Doc.5.1.a
CA-July13-Doc.5.1.aa
5.1.b.Follow-up from previous discussions
  • IT security requirements
  • IT roll-out plan
/ For information
5.1.c.Technical equivalence / For discussion
CA-July13-Doc.5.1.c
5.1.d.Confidentiality claims check (with some clarification on dissemination) / For discussion
CA-July13-Doc.5.1.d
5.1.e.ECHA expert group on endocrine disrupters / For discussion
CA-July13-Doc.5.1.e
5.1.f.Preliminary Article 95 list / For information
CA-July13-Doc.5.1.f
5.1.g.Treated articles / For endorsement
CA-July13-Doc.5.1.g
5.1.h.Borderline cosmetics/biocides / For endorsement
CA-July13-Doc.5.1.h
5.1.i.Biocides and food contact materials / For endorsement
CA-July13-Doc.5.1.i
12 July
Morning Session / 10:00 – 12:30
5.1.j.Comparative assessment / For discussion
CA-July13-Doc.5.1.j
5.1.k.Implementation of Article 91 / For discussion
CA-July13-Doc.5.1.k
5.1.l.In situ generated active substances / For discussion
CA-July13-Doc.5.1.l
CA-July13-Doc.5.1.l.a
5.1.m.MRLs / For information
5.1.n.Mutual recognition agreement with Switzerland / For information
5.1.o.Draft Commission proposal to amend Regulation (EU) No 528/2012 / For information
5.1.p. Guidance note on the concept of placing biocidal products on the market / For discussion
CA-July13-Doc.5.1.p
  1. Policy matters

6.1.Technical meetings
6.2.Guidance documents
6.2.a.Guidance documents on environmental risk mitigation measures for PT 1-5 / For endorsement
CA-July13-Doc.6.2.a
6.2.b.Guidance on dermal absorption assessment for biocidal products authorisation / For endorsement
CA-July13-Doc.6.2.b
6.2.c.Guidance on Efficacy PT08 / For endorsement
CA-July13-Doc.6.2.c
6.2.d.Guidance on Efficacy PT22 / For endorsement
CA-July13-Doc.6.2.d
  1. Requests for opinions

7.1.Appropriate PT for biocides used in oil extraction / For discussion
CA-July13-Doc.7.1
7.2.Appropriate PT for biocides used in water filters / For decision
CA-July13-Doc.7.2
  1. Review programme

8.1.Progress report on substances under evaluation / For information
CA-July13-Doc.8.1
8.2.Annex I-inclusions - Deadlines for decision making / For information
CA-July13-Doc.8.2
8.3.Establishment of a work programme to meet the 2024 deadline / For discussion
CA-July13-Doc.8.3
8.4.Questions on in situ generated CO2 / For decision
CA-July13-Doc.8.4
8.5.Efficacy testing of treated articles / For discussion
CA-July13-Doc.8.5
8.6.Bacterial resistance and substance approval / For discussion
CA-July13-Doc.8.6
8.7.Report of ad hoc meeting on antifoulings / For information
  1. New active substances

9.1.Progress report on substances under evaluation / For information
CA-July13-Doc.9.1
12 July
Afternoon Session / 14:00 – 16:00
  1. Enforcement and implementation issues

10.1.Use of copper in PT2, 5 and 11 / For information
  1. Product authorisations

11.1.Report from the Product Authorisation and Mutual Recognition Facilitation Group / For information
11.2.Status report on notifications made in accordance with Article 4(4) of the Directive / For information
CA-July13-Doc.11.2
11.3.Application of Article 23(4) of the BPR to anticoagulant rodenticides for which the authorisation decision will be taken after 1 September 2013 / For endorsement
CA-July13-Doc.11.3
  1. New policy developments which may affect the biocides regulatory framework

12.1.Commission recommendation establishing guidelines for the distinction between feed materials, feed additives, biocidal products and veterinary medicinal products / For information
12.2.7th ad hoc group meeting under the Community Strategy for endocrine disruptors / For information
  1. International Matters

  1. AOB

14.1.List of Competent Authorities and other Contact Pointsand of list of Members of the Consultation Group / For information
CA-July13-Doc. 14.1
CA-July13-Doc. 14.1a

Next meetings (provisional):

2013

PA&MRFG/CG / CA / TM / BPC
9 July 2013 / 10 - 12 July 2013
24 September 2013 / 25 - 27 September 2013 / TM III 16-20 September 2013 / 9-10 October 2013
8 October 2013 (pm)
(tbd) December 2013 / 10 - 12 December 2013 / TM IV 25-29 November 2013

2014-2015

CG / CA / BPC
15 January 2014 / 11-13 February 2014
11 March 2014 / 12-14 March 2014 / 8-10 April 2014
13 May 2014 / 14-16 May 2014 / 17-19 June 2014
10 July 2014 / 30 September - 2 October 2014
16 September 2014 / 17-19 September 2014 / 2-4 December 2014
11 November 2014 / 12-14 November 2014 / 3-5 February 2015
14-16 April 2015
16-18 June 2015
29 September - 1 October 2015
1-3 December 2015

1